UiPath (NYSE:PATH) Trading Down 0.9%

UiPath Inc. (NYSE:PATH) shares dropped 0.9% on Tuesday . The stock traded as low as $19.42 and last traded at $19.58. Approximately 986,969 shares traded hands during trading, a decline of 88% from the average daily volume of 8,561,100 shares. The stock had previously closed at $19.76.

Analysts Set New Price Targets

A number of research analysts have weighed in on PATH shares. TD Cowen boosted their target price on shares of UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a research note on Thursday, March 14th. Canaccord Genuity Group raised their target price on UiPath from $27.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, March 15th. Evercore ISI upped their price target on UiPath from $24.00 to $27.00 and gave the company an “in-line” rating in a research report on Thursday, March 14th. DA Davidson lifted their price objective on UiPath from $20.00 to $24.00 and gave the stock a “neutral” rating in a report on Thursday, March 14th. Finally, Barclays increased their target price on shares of UiPath from $23.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Friday, March 15th. Nine analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, UiPath has a consensus rating of “Moderate Buy” and an average price target of $27.41.

UiPath Stock Performance

The stock has a 50-day moving average price of $22.08 and a 200-day moving average price of $21.64. The stock has a market cap of $10.79 billion, a P/E ratio of -115.17 and a beta of 0.96.

UiPath (NYSE:PATH) last issued its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The firm had revenue of $405.25 million for the quarter, compared to analyst estimates of $383.32 million. Sell-side analysts forecast that UiPath Inc. will post -0.04 earnings per share for the current fiscal year.

Insider Transactions at UiPath

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of UiPath stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00. Following the transaction, the chief financial officer now directly owns 87,505 shares of the company’s stock, valued at $1,998,614.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In the last three months, insiders sold 72,000 shares of company stock worth $1,591,360. 31.03% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Mark Sheptoff Financial Planning LLC bought a new position in UiPath during the 4th quarter worth approximately $25,000. HighMark Wealth Management LLC purchased a new stake in shares of UiPath during the fourth quarter valued at approximately $27,000. Cypress Capital Management LLC WY bought a new position in shares of UiPath in the fourth quarter worth approximately $29,000. GAMMA Investing LLC purchased a new position in shares of UiPath in the fourth quarter worth $36,000. Finally, FNY Investment Advisers LLC purchased a new stake in UiPath during the 4th quarter valued at $40,000. Hedge funds and other institutional investors own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.